| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 21 | 2025 | 502 | 3.710 |
Why?
|
| Sinus Thrombosis, Intracranial | 4 | 2024 | 48 | 2.550 |
Why?
|
| Mental Retardation, X-Linked | 5 | 2024 | 71 | 2.510 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 9 | 2025 | 309 | 2.370 |
Why?
|
| Homozygote | 15 | 2024 | 547 | 1.890 |
Why?
|
| Phenotype | 37 | 2025 | 4258 | 1.870 |
Why?
|
| Rett Syndrome | 5 | 2025 | 291 | 1.770 |
Why?
|
| DNA Copy Number Variations | 15 | 2024 | 949 | 1.660 |
Why?
|
| Mutation | 35 | 2025 | 5845 | 1.450 |
Why?
|
| Intellectual Disability | 16 | 2025 | 1056 | 1.420 |
Why?
|
| Pedigree | 33 | 2025 | 1604 | 1.380 |
Why?
|
| Microcephaly | 13 | 2025 | 330 | 1.360 |
Why?
|
| Charcot-Marie-Tooth Disease | 6 | 2023 | 199 | 1.350 |
Why?
|
| Zebrafish | 10 | 2025 | 380 | 1.100 |
Why?
|
| Child, Preschool | 41 | 2025 | 13882 | 1.010 |
Why?
|
| Genomics | 6 | 2022 | 1501 | 0.970 |
Why?
|
| Arthrogryposis | 3 | 2022 | 35 | 0.960 |
Why?
|
| Nervous System Malformations | 6 | 2024 | 130 | 0.950 |
Why?
|
| Mutation, Missense | 9 | 2025 | 874 | 0.900 |
Why?
|
| Child | 45 | 2025 | 24173 | 0.880 |
Why?
|
| Exome | 16 | 2020 | 1033 | 0.880 |
Why?
|
| Humans | 115 | 2025 | 124705 | 0.810 |
Why?
|
| Nuclear Proteins | 6 | 2024 | 1266 | 0.790 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2022 | 8 | 0.780 |
Why?
|
| Alleles | 16 | 2025 | 1615 | 0.770 |
Why?
|
| Infant | 28 | 2025 | 12384 | 0.730 |
Why?
|
| Male | 70 | 2025 | 61317 | 0.730 |
Why?
|
| Developmental Disabilities | 6 | 2024 | 711 | 0.720 |
Why?
|
| DNA Replication | 2 | 2013 | 352 | 0.700 |
Why?
|
| Adolescent | 34 | 2025 | 19221 | 0.700 |
Why?
|
| Membrane Proteins | 8 | 2024 | 1529 | 0.690 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 295 | 0.670 |
Why?
|
| Genetic Association Studies | 7 | 2025 | 778 | 0.660 |
Why?
|
| Female | 64 | 2025 | 66577 | 0.640 |
Why?
|
| Gene Rearrangement | 4 | 2021 | 320 | 0.640 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 336 | 0.640 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2024 | 3154 | 0.640 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2021 | 170 | 0.620 |
Why?
|
| De Lange Syndrome | 4 | 2018 | 44 | 0.620 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 139 | 0.600 |
Why?
|
| Gene Duplication | 7 | 2024 | 362 | 0.590 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 194 | 0.590 |
Why?
|
| Parents | 2 | 2024 | 1022 | 0.570 |
Why?
|
| Genetic Markers | 1 | 2019 | 603 | 0.560 |
Why?
|
| Scoliosis | 4 | 2020 | 135 | 0.550 |
Why?
|
| Loss of Heterozygosity | 3 | 2021 | 124 | 0.540 |
Why?
|
| Caregivers | 1 | 2022 | 571 | 0.530 |
Why?
|
| Stroke | 2 | 2022 | 986 | 0.530 |
Why?
|
| Vesicular Transport Proteins | 4 | 2024 | 120 | 0.520 |
Why?
|
| Nerve Tissue Proteins | 5 | 2022 | 1113 | 0.520 |
Why?
|
| Brain Diseases | 3 | 2024 | 296 | 0.520 |
Why?
|
| Movement Disorders | 3 | 2024 | 222 | 0.520 |
Why?
|
| Dystonia | 3 | 2023 | 171 | 0.510 |
Why?
|
| Myelin Proteins | 2 | 2015 | 75 | 0.510 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2023 | 558 | 0.510 |
Why?
|
| Polyneuropathies | 1 | 2015 | 29 | 0.490 |
Why?
|
| Epilepsy | 7 | 2022 | 873 | 0.480 |
Why?
|
| Genetic Variation | 7 | 2021 | 1498 | 0.470 |
Why?
|
| Adult | 24 | 2025 | 29554 | 0.470 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 147 | 0.460 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 228 | 0.440 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 3 | 2023 | 24 | 0.440 |
Why?
|
| Vocal Cord Paralysis | 1 | 2015 | 66 | 0.440 |
Why?
|
| Abnormalities, Multiple | 4 | 2020 | 958 | 0.440 |
Why?
|
| Congenital Disorders of Glycosylation | 2 | 2025 | 46 | 0.440 |
Why?
|
| DNA Breaks | 1 | 2013 | 26 | 0.430 |
Why?
|
| Loss of Function Mutation | 3 | 2024 | 149 | 0.430 |
Why?
|
| Proteins | 4 | 2016 | 1036 | 0.420 |
Why?
|
| Genetic Heterogeneity | 3 | 2024 | 125 | 0.410 |
Why?
|
| Trichothiodystrophy Syndromes | 1 | 2012 | 1 | 0.410 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2012 | 21 | 0.410 |
Why?
|
| Quality of Life | 1 | 2022 | 1936 | 0.400 |
Why?
|
| Animals | 34 | 2025 | 34235 | 0.390 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2015 | 124 | 0.390 |
Why?
|
| Constipation | 2 | 2023 | 114 | 0.380 |
Why?
|
| Cell Cycle Proteins | 6 | 2019 | 656 | 0.380 |
Why?
|
| Turkey | 5 | 2021 | 64 | 0.380 |
Why?
|
| Receptors, Immunologic | 2 | 2022 | 112 | 0.380 |
Why?
|
| Lissencephaly | 2 | 2022 | 10 | 0.370 |
Why?
|
| Epilepsy, Generalized | 2 | 2022 | 64 | 0.360 |
Why?
|
| Comparative Genomic Hybridization | 7 | 2024 | 572 | 0.360 |
Why?
|
| Genome, Human | 5 | 2024 | 1274 | 0.350 |
Why?
|
| Young Adult | 12 | 2025 | 9023 | 0.350 |
Why?
|
| Cerebellar Diseases | 3 | 2020 | 73 | 0.350 |
Why?
|
| Cohort Studies | 10 | 2024 | 4799 | 0.340 |
Why?
|
| RNA, Transfer | 2 | 2025 | 72 | 0.340 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 448 | 0.340 |
Why?
|
| DNA Repair | 1 | 2013 | 585 | 0.340 |
Why?
|
| Growth Disorders | 3 | 2020 | 209 | 0.340 |
Why?
|
| Anticoagulants | 3 | 2024 | 592 | 0.340 |
Why?
|
| Neuromuscular Diseases | 2 | 2020 | 56 | 0.330 |
Why?
|
| Mosaicism | 2 | 2024 | 239 | 0.330 |
Why?
|
| Infant, Newborn | 8 | 2023 | 8163 | 0.330 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2011 | 673 | 0.320 |
Why?
|
| Head and Neck Neoplasms | 3 | 2008 | 504 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2008 | 101 | 0.290 |
Why?
|
| Chromosomes, Human, X | 3 | 2021 | 157 | 0.280 |
Why?
|
| Atrophy | 5 | 2020 | 230 | 0.280 |
Why?
|
| Mice | 20 | 2024 | 17645 | 0.270 |
Why?
|
| Eczema | 2 | 2020 | 29 | 0.270 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2023 | 245 | 0.260 |
Why?
|
| Inheritance Patterns | 2 | 2019 | 127 | 0.260 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2024 | 882 | 0.260 |
Why?
|
| Neoplasm Proteins | 3 | 2023 | 670 | 0.260 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 3715 | 0.260 |
Why?
|
| Calcium Channels | 2 | 2019 | 160 | 0.250 |
Why?
|
| Zebrafish Proteins | 2 | 2025 | 115 | 0.250 |
Why?
|
| Base Sequence | 7 | 2017 | 3101 | 0.250 |
Why?
|
| Muscular Dystrophies | 2 | 2023 | 52 | 0.250 |
Why?
|
| Siblings | 2 | 2024 | 197 | 0.240 |
Why?
|
| Repressor Proteins | 3 | 2020 | 815 | 0.240 |
Why?
|
| tRNA Methyltransferases | 1 | 2025 | 5 | 0.240 |
Why?
|
| Bardet-Biedl Syndrome | 2 | 2016 | 38 | 0.240 |
Why?
|
| Brain | 7 | 2024 | 2996 | 0.240 |
Why?
|
| Retrospective Studies | 8 | 2024 | 16263 | 0.240 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2018 | 209 | 0.240 |
Why?
|
| Glucosyltransferases | 1 | 2025 | 49 | 0.240 |
Why?
|
| Neurons | 3 | 2024 | 1932 | 0.230 |
Why?
|
| Spindle Apparatus | 1 | 2025 | 63 | 0.230 |
Why?
|
| Drosophila melanogaster | 2 | 2024 | 766 | 0.230 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2019 | 443 | 0.230 |
Why?
|
| Methyltransferases | 1 | 2025 | 71 | 0.230 |
Why?
|
| Heterozygote | 7 | 2018 | 671 | 0.230 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 78 | 0.220 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2022 | 81 | 0.220 |
Why?
|
| Genes, Dominant | 2 | 2024 | 245 | 0.220 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 5154 | 0.220 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 375 | 0.220 |
Why?
|
| Cerebellum | 4 | 2021 | 415 | 0.220 |
Why?
|
| Genotype | 5 | 2024 | 2558 | 0.210 |
Why?
|
| Fibroblasts | 4 | 2023 | 885 | 0.210 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2023 | 45 | 0.210 |
Why?
|
| Neural Stem Cells | 1 | 2024 | 119 | 0.210 |
Why?
|
| Membrane Transport Proteins | 1 | 2024 | 176 | 0.210 |
Why?
|
| Biological Variation, Population | 2 | 2024 | 24 | 0.210 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2024 | 263 | 0.210 |
Why?
|
| Family | 5 | 2020 | 564 | 0.200 |
Why?
|
| Cell Division | 1 | 2024 | 781 | 0.200 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2022 | 14 | 0.200 |
Why?
|
| Urogenital Abnormalities | 2 | 2022 | 154 | 0.200 |
Why?
|
| Myokymia | 1 | 2022 | 8 | 0.200 |
Why?
|
| Eye Abnormalities | 2 | 2021 | 104 | 0.200 |
Why?
|
| Haplotypes | 1 | 2024 | 522 | 0.200 |
Why?
|
| Contracture | 1 | 2022 | 24 | 0.200 |
Why?
|
| Muscular Diseases | 1 | 2023 | 104 | 0.200 |
Why?
|
| Software | 2 | 2024 | 683 | 0.200 |
Why?
|
| Bile Acids and Salts | 1 | 2024 | 242 | 0.200 |
Why?
|
| Apyrase | 1 | 2022 | 19 | 0.200 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2022 | 10 | 0.200 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 21 | 0.200 |
Why?
|
| Histone Deacetylases | 2 | 2020 | 109 | 0.200 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 29 | 0.200 |
Why?
|
| Dystonic Disorders | 1 | 2023 | 85 | 0.190 |
Why?
|
| Angelman Syndrome | 1 | 2022 | 68 | 0.190 |
Why?
|
| Cranial Sinuses | 1 | 2022 | 12 | 0.190 |
Why?
|
| Neural Conduction | 3 | 2020 | 92 | 0.190 |
Why?
|
| Sequence Deletion | 4 | 2021 | 524 | 0.190 |
Why?
|
| Electroencephalography | 2 | 2025 | 864 | 0.190 |
Why?
|
| Decompressive Craniectomy | 1 | 2022 | 13 | 0.190 |
Why?
|
| Cell Adhesion Molecules | 1 | 2023 | 230 | 0.190 |
Why?
|
| Chromosome Deletion | 2 | 2019 | 646 | 0.190 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 9 | 0.190 |
Why?
|
| MELAS Syndrome | 1 | 2022 | 33 | 0.190 |
Why?
|
| Syndrome | 5 | 2023 | 1119 | 0.190 |
Why?
|
| Brain Edema | 1 | 2022 | 68 | 0.190 |
Why?
|
| Facies | 4 | 2020 | 153 | 0.190 |
Why?
|
| T-Box Domain Proteins | 2 | 2020 | 113 | 0.190 |
Why?
|
| Urinary Tract | 1 | 2022 | 60 | 0.180 |
Why?
|
| AlkB Homolog 8, tRNA Methyltransferase | 1 | 2021 | 4 | 0.180 |
Why?
|
| Alu Elements | 1 | 2021 | 65 | 0.180 |
Why?
|
| Chromosome Duplication | 1 | 2021 | 147 | 0.180 |
Why?
|
| Mediator Complex | 1 | 2021 | 51 | 0.180 |
Why?
|
| Symporters | 1 | 2021 | 69 | 0.170 |
Why?
|
| Fibrillar Collagens | 1 | 2020 | 15 | 0.170 |
Why?
|
| Founder Effect | 1 | 2020 | 32 | 0.170 |
Why?
|
| Chromosome Breakpoints | 3 | 2019 | 80 | 0.170 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 79 | 0.170 |
Why?
|
| Psychometrics | 1 | 2024 | 673 | 0.170 |
Why?
|
| Netrins | 1 | 2019 | 3 | 0.170 |
Why?
|
| Encephalitis | 1 | 2021 | 109 | 0.170 |
Why?
|
| Ribosomes | 1 | 2020 | 137 | 0.170 |
Why?
|
| Hip Dislocation | 1 | 2020 | 28 | 0.170 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2020 | 45 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 181 | 0.170 |
Why?
|
| Muscle Hypotonia | 2 | 2022 | 187 | 0.160 |
Why?
|
| Alopecia | 2 | 2023 | 39 | 0.160 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 2885 | 0.160 |
Why?
|
| Molecular Sequence Data | 6 | 2016 | 3891 | 0.160 |
Why?
|
| Connectin | 1 | 2019 | 27 | 0.160 |
Why?
|
| Mitochondrial Diseases | 1 | 2021 | 133 | 0.160 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 238 | 0.160 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2019 | 106 | 0.160 |
Why?
|
| Osteomyelitis | 1 | 2022 | 205 | 0.160 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 100 | 0.160 |
Why?
|
| Autistic Disorder | 1 | 2022 | 350 | 0.160 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2019 | 42 | 0.160 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2021 | 150 | 0.160 |
Why?
|
| Genes, Recessive | 4 | 2024 | 185 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 4 | 2024 | 1757 | 0.150 |
Why?
|
| Frameshift Mutation | 2 | 2023 | 179 | 0.150 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 58 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 240 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2024 | 2634 | 0.140 |
Why?
|
| Fibromatosis, Gingival | 1 | 2017 | 4 | 0.140 |
Why?
|
| Exons | 2 | 2017 | 797 | 0.140 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 782 | 0.140 |
Why?
|
| Spasms, Infantile | 1 | 2019 | 171 | 0.140 |
Why?
|
| Naegleria fowleri | 1 | 2017 | 4 | 0.140 |
Why?
|
| Central Nervous System Protozoal Infections | 1 | 2017 | 4 | 0.140 |
Why?
|
| Gene Dosage | 1 | 2019 | 440 | 0.140 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 236 | 0.140 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 470 | 0.140 |
Why?
|
| Consanguinity | 3 | 2022 | 115 | 0.130 |
Why?
|
| Autophagy | 1 | 2020 | 393 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 553 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 732 | 0.130 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2019 | 369 | 0.130 |
Why?
|
| Myelin P0 Protein | 1 | 2015 | 25 | 0.120 |
Why?
|
| Genetic Load | 1 | 2015 | 5 | 0.120 |
Why?
|
| Sequence Alignment | 2 | 2020 | 621 | 0.120 |
Why?
|
| Anxiety | 1 | 2022 | 959 | 0.120 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2015 | 8 | 0.120 |
Why?
|
| Amino Acid Sequence | 5 | 2021 | 2717 | 0.120 |
Why?
|
| Hypogonadism | 2 | 2019 | 284 | 0.120 |
Why?
|
| Chromosome Segregation | 3 | 2025 | 63 | 0.120 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2015 | 7 | 0.120 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2015 | 84 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 920 | 0.120 |
Why?
|
| Penetrance | 2 | 2015 | 102 | 0.120 |
Why?
|
| Gestational Age | 1 | 2019 | 1161 | 0.120 |
Why?
|
| Hypopituitarism | 1 | 2015 | 17 | 0.120 |
Why?
|
| Prevalence | 1 | 2021 | 2446 | 0.120 |
Why?
|
| Motor Neurons | 1 | 2015 | 140 | 0.120 |
Why?
|
| Pituitary Gland | 1 | 2015 | 82 | 0.120 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2014 | 16 | 0.110 |
Why?
|
| Anodontia | 1 | 2014 | 30 | 0.110 |
Why?
|
| Middle Aged | 7 | 2024 | 26884 | 0.110 |
Why?
|
| Glycosylation | 2 | 2025 | 121 | 0.110 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 131 | 0.110 |
Why?
|
| Phosphotransferases | 1 | 2014 | 40 | 0.110 |
Why?
|
| Anophthalmos | 1 | 2014 | 24 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2025 | 6132 | 0.110 |
Why?
|
| X Chromosome Inactivation | 3 | 2021 | 62 | 0.110 |
Why?
|
| Refsum Disease | 1 | 2013 | 4 | 0.110 |
Why?
|
| Age of Onset | 1 | 2015 | 591 | 0.110 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2013 | 36 | 0.110 |
Why?
|
| Drosophila | 3 | 2024 | 775 | 0.110 |
Why?
|
| Gene Expression Regulation | 3 | 2024 | 2524 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 1290 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2015 | 4534 | 0.110 |
Why?
|
| Armadillo Domain Proteins | 1 | 2013 | 9 | 0.110 |
Why?
|
| DNA Mutational Analysis | 5 | 2014 | 794 | 0.110 |
Why?
|
| Dyneins | 1 | 2013 | 13 | 0.110 |
Why?
|
| Depression | 1 | 2022 | 1236 | 0.110 |
Why?
|
| Kartagener Syndrome | 1 | 2013 | 14 | 0.110 |
Why?
|
| Receptors, Notch | 1 | 2015 | 201 | 0.110 |
Why?
|
| Gene Frequency | 3 | 2020 | 724 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 107 | 0.110 |
Why?
|
| Disease | 1 | 2014 | 129 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 351 | 0.100 |
Why?
|
| Curcumin | 1 | 2013 | 41 | 0.100 |
Why?
|
| Genomic Structural Variation | 2 | 2024 | 86 | 0.100 |
Why?
|
| Body Patterning | 1 | 2013 | 122 | 0.100 |
Why?
|
| Eye Proteins | 1 | 2014 | 218 | 0.100 |
Why?
|
| Respiratory System | 1 | 2013 | 97 | 0.100 |
Why?
|
| Obesity | 1 | 2024 | 2248 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2014 | 404 | 0.100 |
Why?
|
| Cilia | 1 | 2013 | 74 | 0.100 |
Why?
|
| RNA Interference | 1 | 2014 | 500 | 0.100 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 120 | 0.100 |
Why?
|
| Protein Conformation | 2 | 2014 | 834 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 389 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 293 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2022 | 3560 | 0.100 |
Why?
|
| Gene Order | 1 | 2012 | 79 | 0.100 |
Why?
|
| Chromosome Mapping | 2 | 2019 | 1080 | 0.090 |
Why?
|
| Mammals | 2 | 2023 | 258 | 0.090 |
Why?
|
| IgA Deficiency | 1 | 2011 | 5 | 0.090 |
Why?
|
| Rare Diseases | 2 | 2024 | 191 | 0.090 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2011 | 22 | 0.090 |
Why?
|
| Tubulin | 2 | 2022 | 103 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 306 | 0.090 |
Why?
|
| Lysine-tRNA Ligase | 1 | 2010 | 4 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2008 | 204 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2418 | 0.090 |
Why?
|
| DNA Helicases | 2 | 2023 | 231 | 0.080 |
Why?
|
| Risk Factors | 1 | 2024 | 10249 | 0.080 |
Why?
|
| Axons | 2 | 2022 | 370 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2022 | 2594 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2022 | 3742 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2012 | 789 | 0.080 |
Why?
|
| Transcriptome | 1 | 2015 | 953 | 0.070 |
Why?
|
| Receptor, EphA2 | 1 | 2008 | 29 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2014 | 1002 | 0.070 |
Why?
|
| Kidney | 3 | 2022 | 1367 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4396 | 0.070 |
Why?
|
| Microsatellite Repeats | 1 | 2008 | 221 | 0.070 |
Why?
|
| Drosophila Proteins | 2 | 2024 | 712 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2010 | 1079 | 0.070 |
Why?
|
| Cell Line | 2 | 2023 | 2756 | 0.070 |
Why?
|
| Cell Movement | 2 | 2021 | 846 | 0.070 |
Why?
|
| Esophageal Neoplasms | 1 | 2011 | 372 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2023 | 737 | 0.070 |
Why?
|
| Spine | 2 | 2019 | 142 | 0.070 |
Why?
|
| Gastrulation | 2 | 2016 | 16 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 701 | 0.060 |
Why?
|
| Centrosome | 1 | 2025 | 35 | 0.060 |
Why?
|
| Seizures | 2 | 2021 | 870 | 0.060 |
Why?
|
| Ethanolamine | 1 | 2024 | 7 | 0.060 |
Why?
|
| Databases, Genetic | 2 | 2019 | 473 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2008 | 2821 | 0.060 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2025 | 80 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 549 | 0.060 |
Why?
|
| Choline | 1 | 2024 | 54 | 0.060 |
Why?
|
| Receptors, Virus | 1 | 2024 | 107 | 0.060 |
Why?
|
| Sensation Disorders | 1 | 2024 | 22 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2025 | 217 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2016 | 270 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2024 | 92 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2024 | 120 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2007 | 799 | 0.050 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 1686 | 0.050 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2023 | 12 | 0.050 |
Why?
|
| RNA-Binding Proteins | 2 | 2020 | 573 | 0.050 |
Why?
|
| Interferons | 1 | 2024 | 125 | 0.050 |
Why?
|
| Mevalonic Acid | 1 | 2023 | 19 | 0.050 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2023 | 27 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2023 | 39 | 0.050 |
Why?
|
| Survival Rate | 1 | 2008 | 2055 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2023 | 26 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2024 | 190 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2023 | 92 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 24 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 88 | 0.050 |
Why?
|
| Amines | 1 | 2022 | 36 | 0.050 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2022 | 15 | 0.050 |
Why?
|
| ADAMTS Proteins | 1 | 2022 | 9 | 0.050 |
Why?
|
| Tremor | 1 | 2024 | 129 | 0.050 |
Why?
|
| Reverse Genetics | 1 | 2022 | 15 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 76 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 167 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2024 | 191 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2023 | 121 | 0.050 |
Why?
|
| Dysarthria | 1 | 2022 | 22 | 0.050 |
Why?
|
| Histidine | 1 | 2022 | 73 | 0.050 |
Why?
|
| Egypt | 1 | 2021 | 23 | 0.050 |
Why?
|
| Prognosis | 2 | 2008 | 4620 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2022 | 142 | 0.050 |
Why?
|
| Paraplegia | 1 | 2022 | 93 | 0.050 |
Why?
|
| Nitrogen | 1 | 2022 | 146 | 0.050 |
Why?
|
| Calpain | 1 | 2021 | 41 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2019 | 760 | 0.050 |
Why?
|
| Glycogen | 1 | 2021 | 63 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2008 | 3293 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 223 | 0.050 |
Why?
|
| Myopathy, Central Core | 1 | 2020 | 5 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 46 | 0.040 |
Why?
|
| Glutamine | 1 | 2022 | 215 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 2020 | 28 | 0.040 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2020 | 22 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 1892 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 429 | 0.040 |
Why?
|
| Electromyography | 1 | 2020 | 165 | 0.040 |
Why?
|
| Myositis | 1 | 2020 | 61 | 0.040 |
Why?
|
| Biological Evolution | 1 | 2021 | 225 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2021 | 226 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2024 | 365 | 0.040 |
Why?
|
| Bone Development | 1 | 2020 | 57 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2020 | 229 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 359 | 0.040 |
Why?
|
| Quadriplegia | 1 | 2020 | 33 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 1492 | 0.040 |
Why?
|
| Minichromosome Maintenance Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2020 | 88 | 0.040 |
Why?
|
| Metabolome | 1 | 2022 | 293 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 172 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2020 | 152 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 357 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 526 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 434 | 0.040 |
Why?
|
| Muscle Spasticity | 1 | 2020 | 73 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 243 | 0.040 |
Why?
|
| Deafness | 1 | 2020 | 82 | 0.040 |
Why?
|
| Gene Expression | 2 | 2014 | 1561 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2021 | 369 | 0.040 |
Why?
|
| Microtubules | 1 | 2019 | 189 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 238 | 0.040 |
Why?
|
| Health Status | 1 | 2021 | 374 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2019 | 173 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 216 | 0.040 |
Why?
|
| Cerebellar Ataxia | 1 | 2019 | 66 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2021 | 417 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 253 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2021 | 612 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 329 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2019 | 132 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 278 | 0.040 |
Why?
|
| Cataract | 1 | 2021 | 224 | 0.040 |
Why?
|
| Antigens, Nuclear | 1 | 2018 | 60 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2018 | 87 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 142 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4406 | 0.040 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2020 | 252 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 429 | 0.040 |
Why?
|
| Incidence | 1 | 2024 | 3115 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1234 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 452 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1896 | 0.030 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 22 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3728 | 0.030 |
Why?
|
| Apoptosis | 1 | 2022 | 1802 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1287 | 0.030 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Myelin P2 Protein | 1 | 2015 | 9 | 0.030 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2015 | 22 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2015 | 43 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 947 | 0.030 |
Why?
|
| Exonucleases | 1 | 2015 | 23 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 216 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 27 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 546 | 0.030 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2015 | 39 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 1708 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3415 | 0.030 |
Why?
|
| Hamartoma | 1 | 2015 | 52 | 0.030 |
Why?
|
| Corneal Opacity | 1 | 2014 | 23 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 2014 | 31 | 0.030 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2014 | 22 | 0.030 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 65 | 0.030 |
Why?
|
| Cerebrum | 1 | 2014 | 33 | 0.030 |
Why?
|
| Coloboma | 1 | 2014 | 45 | 0.030 |
Why?
|
| Microphthalmos | 1 | 2014 | 60 | 0.030 |
Why?
|
| Inflammation | 1 | 2021 | 1440 | 0.030 |
Why?
|
| Axoneme | 1 | 2013 | 7 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 156 | 0.030 |
Why?
|
| Endoribonucleases | 1 | 2014 | 84 | 0.030 |
Why?
|
| X Chromosome | 1 | 2014 | 338 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2013 | 56 | 0.030 |
Why?
|
| Aged | 2 | 2008 | 19830 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 68 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2013 | 61 | 0.030 |
Why?
|
| Cleft Palate | 1 | 2015 | 140 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2018 | 1024 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 815 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 383 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2014 | 339 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 765 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 276 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 162 | 0.020 |
Why?
|
| Retina | 1 | 2015 | 450 | 0.020 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2011 | 27 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 2048 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 354 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 64 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 1006 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2007 | 212 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 539 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 686 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 466 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 1252 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 1504 | 0.010 |
Why?
|
| United States | 1 | 2019 | 10866 | 0.010 |
Why?
|